戻る Agenda
Topic 5 Session 5: Effectiveness of Risk Minimisation Measures
Speaker(s)
Effectiveness of Risk Minimisation Measures
Jan Petracek, MD, MSc
Ivigee, Czech Republic
CEO
Holiday Inn London Kensington Forum
2017年2月27日 (月) 午前 8:00 - 2017年3月03日 (金) 午後 1:30
97 Cromwell Road, London, SW7 4DN, United Kingdom
Joint MHRA/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing
The 5 days of training include a comprehensive overview of the core processes and systems in place and the latest news on the international harmonisation and standardisation activities in pharmacovigilance.